HGC Investment Management’s ACELYRIN SLRN Stock Holding History
Bought
Maintained
Sold
Other funds holding SLRN
HGC Investment Management's SLRN Position: Q2 2025 in Review
HGC Investment Management sold out of ACELYRIN (SLRN) in Q2 2025, closing a stake of 70,425 shares — an estimated $174K sold.
HGC Investment Management first reported a position in SLRN in Q1 2025 and held it in 1 quarter. The position peaked at $174K in Q1 2025. 2 funds tracked by Wall St. Rank hold SLRN as of Q2 2025.
- HGC Investment Management reported no remaining ACELYRIN position as of Q2 2025 after selling out during the quarter.
- HGC Investment Management sold 70,425 ACELYRIN shares in Q2 2025, an estimated $174K.
- HGC Investment Management first reported a position in ACELYRIN in Q1 2025 and held it in 1 quarter.
- HGC Investment Management's ACELYRIN position peaked at $174K in Q1 2025.
- 2 funds tracked by Wall St. Rank held ACELYRIN as of Q2 2025.
Based on HGC Investment Management's 13F filing for Q2 2025, filed 14 Aug 2025.